METTL14 and acute myeloid leukemia: As one striking example, both m6A writer METTL14 [50] and m6A eraser FTO [53] are found to be highly expressed in AMLs, even in the same subtype—as in t(11q23) and t(15;17)—and play critical roles in AML development.